Filing Details

Accession Number:
0001209191-22-055466
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-03 14:07:58
Reporting Period:
2022-11-03
Accepted Time:
2022-11-03 14:07:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1651311 Merus N.v. MRUS Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1682126 Ante Sven Lundberg C/O Merus N.v.
Yalelaan 62
Utrecht P7 3584 CM
President, Ceo & Pfo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2022-11-03 14,706 $14.38 40,576 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares 28,246 Indirect Ante Sven Lundberg Qualified Annuity Interest Trust II
Common Shares 9,249 Indirect Ante Sven Lundberg Qualified Annuity Interest Trust III
Footnotes
  1. Purchased pursuant to 10B5-1 plan dated 6/10/2022
  2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.36 to $16.00, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.